Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025.
- DOI
- 10.1007/s43441-026-01044-5
- Published
- 2026 Sep 9
- Container
- Therapeutic innovation & regulatory science
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-026-01044-5,
title = {Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025.},
author = {Bouwman L and Almeida D and Jonker C and Leufkens H and Sepodes B and Torre C},
year = {2026},
journal = {Therapeutic innovation \& regulatory science},
doi = {10.1007/s43441-026-01044-5},
url = {https://doi.org/10.1007/s43441-026-01044-5}
}RIS
TY - JOUR TI - Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025. AU - Bouwman L AU - Almeida D AU - Jonker C AU - Leufkens H AU - Sepodes B AU - Torre C PY - 2026 JO - Therapeutic innovation & regulatory science DO - 10.1007/s43441-026-01044-5 UR - https://doi.org/10.1007/s43441-026-01044-5 ER -
APA
L, B., D, A., C, J., H, L., B, S., & C, T. (2026). Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-026-01044-5
Source records
- pubmed · retrieved 2026-09-25T08:34:35.764Z